The Obama administration aggressively pursued the pharmaceutical industry to make a deal in support of health care reform legislation in mid-2009, according to a series of emails released Thursday by Republicans on the House Energy and Commerce Committee.
In particular, pharmaceutical industry executives' correspondence confirmed that White House officials agreed to “kill” efforts on Capitol Hill to allow drugs to be imported from other countries — one of the chief legislative priorities of the industry — to get the industry’s backing.
Read the full story: http://hcp.lv/KQSakm
Source: Politico
FDA Approves bluebird bio's Lovo-Cel Gene Therapy for Sickle Cell Disease
December 10th 2023The decision was supported by efficacy data from 36 patients from the ongoing phase 1/2 HGB-206 trial (NCT02140554) and 2 patients in the phase 3 HGB-210 trial (NCT04293185). It was the second approval from FDA for a gene therapy for sickle cell disease.
Read More